Argus Safety Certification Exam – 150-
Question Practice Exam with Answers and
Rationales
Overview:
This exam is designed to help candidates prepare for the Argus Safety Certification by providing
a comprehensive set of 150 multiple-choice questions covering all key aspects of
pharmacovigilance case processing in Argus Safety. Each question includes the correct answer
in bold and a rationale to explain the reasoning.
Key topics covered:
Case Management: Case entry, status tracking, follow-up, and workflow sequencing
Adverse Event Reporting: Seriousness, expected vs. unexpected events, and expedited
reporting
Regulatory Compliance: ICSR, PSUR, and ICH E2B guidelines
MedDRA Coding: LLT, PT, HLT, HLGT, SOC hierarchy, and coding best practices
WHO Drug Dictionary: Coding suspect and concomitant products
Duplicate Detection & Audit Trail: Ensuring data integrity and traceability
Roles & Responsibilities: Data Entry Operator, Safety Reviewer, and Manager
responsibilities
Reporting & Analytics: Dashboards, signal detection, and trend analysis
Purpose:
To assess readiness for the Argus Safety Certification Exam
To reinforce understanding of pharmacovigilance principles and Argus Safety
workflows
To provide a comprehensive study and revision tool with rationales for deeper learning
Q1. Which of the following is the primary purpose of Argus Safety?
A) Managing clinical trial finances
B) Recording and processing adverse event reports
C) Marketing pharmaceutical products
D) Performing statistical analysis on sales data
Answer: B
,Rationale: Argus Safety is designed to capture, manage, and report adverse events
and ensure regulatory compliance.
Q2. What does ICSR stand for in pharmacovigilance?
A) International Case Safety Report
B) Individual Case Safety Report
C) Internal Clinical Safety Record
D) Immediate Case Safety Review
Answer: B
Rationale: ICSR refers to an Individual Case Safety Report, a record of a single
patient’s adverse event.
Q3. Which coding dictionary is used in Argus Safety for adverse events?
A) WHO Drug Dictionary
B) MedDRA
C) ICD-10
D) SNOMED CT
Answer: B
Rationale: MedDRA (Medical Dictionary for Regulatory Activities) is used for
standard coding of adverse events.
Q4. When processing a case in Argus Safety, which field is mandatory?
A) Reporter contact number
B) Patient initials or ID
C) Reporter’s employment status
D) Drug manufacturer address
Answer: B
Rationale: The patient identifier is essential to track and link adverse events; it is a
mandatory field.
Q5. Which of the following is a key step in case follow-up?
A) Assigning MedDRA terms
B) Updating patient outcome information
C) Marketing the drug
D) Scheduling staff meetings
Answer: B
Rationale: Follow-up ensures all relevant information, especially patient
outcomes, is captured for regulatory reporting.
,Q6. In Argus Safety, the “Seriousness” of an adverse event is determined by:
A) Investigator opinion only
B) Regulatory guidelines
C) Patient age
D) Number of drugs the patient is taking
Answer: B
Rationale: Seriousness is defined by regulatory criteria (e.g., death,
hospitalization, disability).
Q7. What type of report is submitted to the FDA for an unexpected serious adverse
event?
A) Periodic Safety Update Report (PSUR)
B) Expedited Individual Case Safety Report (ICSR)
C) Marketing Authorization Report (MAR)
D) Clinical Study Report (CSR)
Answer: B
Rationale: Expedited ICSRs are required for serious, unexpected adverse events.
Q8. Which user role in Argus Safety typically has the ability to validate cases?
A) Data Entry Operator
B) Safety Reviewer
C) Guest User
D) Pharmacovigilance Manager
Answer: B
Rationale: Safety Reviewers validate case data before submission.
Q9. What is the main purpose of MedDRA coding?
A) Track drug sales trends
B) Standardize adverse event terminology
C) Calculate pharmacokinetics
D) Monitor laboratory test performance
Answer: B
Rationale: MedDRA provides a standardized terminology for consistent AE
reporting.
Q10. In Argus Safety, what is a common action if a duplicate case is identified?
A) Merge or link the cases
B) Delete both cases immediately
C) Ignore and continue processing
D) Notify the marketing team
, Answer: A
Rationale: Duplicate cases are merged or linked to maintain accurate safety
records.
Q11. Which of the following best describes “Expedited Reporting”?
A) Routine reporting every 12 months
B) Immediate reporting of serious or unexpected events
C) Reporting only for new drugs
D) Optional reporting to regulators
Answer: B
Rationale: Expedited reporting is required for serious and unexpected adverse
events within regulatory timelines.
Q12. Which Argus Safety feature helps ensure data integrity?
A) Audit Trail
B) Case Comments
C) User Dashboard
D) MedDRA Browser
Answer: A
Rationale: The Audit Trail logs all changes to cases, supporting compliance and
data integrity.
Q13. Which coding dictionary is used for medications in Argus Safety?
A) ICD-10
B) MedDRA
C) WHO Drug Dictionary
D) LOINC
Answer: C
Rationale: The WHO Drug Dictionary standardizes drug names for regulatory
reporting.
Q14. Which action is NOT performed in case processing?
A) Assigning drug and event coding
B) Checking for duplicate cases
C) Designing clinical trials
D) Entering follow-up information
Answer: C
Rationale: Clinical trial design is outside Argus Safety; the system focuses on AE
management.
Question Practice Exam with Answers and
Rationales
Overview:
This exam is designed to help candidates prepare for the Argus Safety Certification by providing
a comprehensive set of 150 multiple-choice questions covering all key aspects of
pharmacovigilance case processing in Argus Safety. Each question includes the correct answer
in bold and a rationale to explain the reasoning.
Key topics covered:
Case Management: Case entry, status tracking, follow-up, and workflow sequencing
Adverse Event Reporting: Seriousness, expected vs. unexpected events, and expedited
reporting
Regulatory Compliance: ICSR, PSUR, and ICH E2B guidelines
MedDRA Coding: LLT, PT, HLT, HLGT, SOC hierarchy, and coding best practices
WHO Drug Dictionary: Coding suspect and concomitant products
Duplicate Detection & Audit Trail: Ensuring data integrity and traceability
Roles & Responsibilities: Data Entry Operator, Safety Reviewer, and Manager
responsibilities
Reporting & Analytics: Dashboards, signal detection, and trend analysis
Purpose:
To assess readiness for the Argus Safety Certification Exam
To reinforce understanding of pharmacovigilance principles and Argus Safety
workflows
To provide a comprehensive study and revision tool with rationales for deeper learning
Q1. Which of the following is the primary purpose of Argus Safety?
A) Managing clinical trial finances
B) Recording and processing adverse event reports
C) Marketing pharmaceutical products
D) Performing statistical analysis on sales data
Answer: B
,Rationale: Argus Safety is designed to capture, manage, and report adverse events
and ensure regulatory compliance.
Q2. What does ICSR stand for in pharmacovigilance?
A) International Case Safety Report
B) Individual Case Safety Report
C) Internal Clinical Safety Record
D) Immediate Case Safety Review
Answer: B
Rationale: ICSR refers to an Individual Case Safety Report, a record of a single
patient’s adverse event.
Q3. Which coding dictionary is used in Argus Safety for adverse events?
A) WHO Drug Dictionary
B) MedDRA
C) ICD-10
D) SNOMED CT
Answer: B
Rationale: MedDRA (Medical Dictionary for Regulatory Activities) is used for
standard coding of adverse events.
Q4. When processing a case in Argus Safety, which field is mandatory?
A) Reporter contact number
B) Patient initials or ID
C) Reporter’s employment status
D) Drug manufacturer address
Answer: B
Rationale: The patient identifier is essential to track and link adverse events; it is a
mandatory field.
Q5. Which of the following is a key step in case follow-up?
A) Assigning MedDRA terms
B) Updating patient outcome information
C) Marketing the drug
D) Scheduling staff meetings
Answer: B
Rationale: Follow-up ensures all relevant information, especially patient
outcomes, is captured for regulatory reporting.
,Q6. In Argus Safety, the “Seriousness” of an adverse event is determined by:
A) Investigator opinion only
B) Regulatory guidelines
C) Patient age
D) Number of drugs the patient is taking
Answer: B
Rationale: Seriousness is defined by regulatory criteria (e.g., death,
hospitalization, disability).
Q7. What type of report is submitted to the FDA for an unexpected serious adverse
event?
A) Periodic Safety Update Report (PSUR)
B) Expedited Individual Case Safety Report (ICSR)
C) Marketing Authorization Report (MAR)
D) Clinical Study Report (CSR)
Answer: B
Rationale: Expedited ICSRs are required for serious, unexpected adverse events.
Q8. Which user role in Argus Safety typically has the ability to validate cases?
A) Data Entry Operator
B) Safety Reviewer
C) Guest User
D) Pharmacovigilance Manager
Answer: B
Rationale: Safety Reviewers validate case data before submission.
Q9. What is the main purpose of MedDRA coding?
A) Track drug sales trends
B) Standardize adverse event terminology
C) Calculate pharmacokinetics
D) Monitor laboratory test performance
Answer: B
Rationale: MedDRA provides a standardized terminology for consistent AE
reporting.
Q10. In Argus Safety, what is a common action if a duplicate case is identified?
A) Merge or link the cases
B) Delete both cases immediately
C) Ignore and continue processing
D) Notify the marketing team
, Answer: A
Rationale: Duplicate cases are merged or linked to maintain accurate safety
records.
Q11. Which of the following best describes “Expedited Reporting”?
A) Routine reporting every 12 months
B) Immediate reporting of serious or unexpected events
C) Reporting only for new drugs
D) Optional reporting to regulators
Answer: B
Rationale: Expedited reporting is required for serious and unexpected adverse
events within regulatory timelines.
Q12. Which Argus Safety feature helps ensure data integrity?
A) Audit Trail
B) Case Comments
C) User Dashboard
D) MedDRA Browser
Answer: A
Rationale: The Audit Trail logs all changes to cases, supporting compliance and
data integrity.
Q13. Which coding dictionary is used for medications in Argus Safety?
A) ICD-10
B) MedDRA
C) WHO Drug Dictionary
D) LOINC
Answer: C
Rationale: The WHO Drug Dictionary standardizes drug names for regulatory
reporting.
Q14. Which action is NOT performed in case processing?
A) Assigning drug and event coding
B) Checking for duplicate cases
C) Designing clinical trials
D) Entering follow-up information
Answer: C
Rationale: Clinical trial design is outside Argus Safety; the system focuses on AE
management.
